Award Abstract # 1510920
UNS: Integrated Tissue Engineering: A Gastrointestinal-Liver Platform to Investigate the Metabolism of Chemicals

NSF Org: CBET
Division of Chemical, Bioengineering, Environmental, and Transport Systems
Recipient: VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY
Initial Amendment Date: September 11, 2015
Latest Amendment Date: September 11, 2015
Award Number: 1510920
Award Instrument: Standard Grant
Program Manager: Stephanie George
CBET
 Division of Chemical, Bioengineering, Environmental, and Transport Systems
ENG
 Directorate for Engineering
Start Date: September 15, 2015
End Date: August 31, 2020 (Estimated)
Total Intended Award Amount: $349,999.00
Total Awarded Amount to Date: $349,999.00
Funds Obligated to Date: FY 2015 = $349,999.00
History of Investigator:
  • Padmavathy Rajagopalan (Principal Investigator)
    padmar@vt.edu
Recipient Sponsored Research Office: Virginia Polytechnic Institute and State University
300 TURNER ST NW
BLACKSBURG
VA  US  24060-3359
(540)231-5281
Sponsor Congressional District: 09
Primary Place of Performance: Virginia Polytechnic Institute and State University
333 Kelly Hall
Blacksburg
VA  US  24061-0001
Primary Place of Performance
Congressional District:
09
Unique Entity Identifier (UEI): QDE5UHE5XD16
Parent UEI: X6KEFGLHSJX7
NSF Program(s): Engineering of Biomed Systems
Primary Program Source: 01001516DB NSF RESEARCH & RELATED ACTIVIT
Program Reference Code(s): 004E, 017E
Program Element Code(s): 534500
Award Agency Code: 4900
Fund Agency Code: 4900
Assistance Listing Number(s): 47.041

ABSTRACT

PI: Rajagopalan, Padmavathy
Proposal Number: 1510920

The gastrointestinal (GI) tract and the liver are organs in the body that absorb and metabolize a portion of ingested chemicals and nutrients. As such, they serve as defense mechanisms against harmful chemicals and pathogens. This project focuses on engineering an integrated GI and liver tissue to obtain information on how these organs work in unison to metabolize chemicals.

The metabolism of a wide range of chemicals, drugs, and pharmaceuticals is mediated by the dual and complementary actions of the gastrointestinal (GI) tract and liver. However, there is a significant lack in understanding how integrating tissue mimics of these organs function cohesively. Current studies that use simplistic monolayers fail to capture the complex interactions in vivo. The PI proposes integrating three-dimensional (3D) tissue mimics of the liver and GI to obtain physiologically relevant information on their relative contributions to the biotransformation of chemicals. The changes in the function and properties of each tissue upon exposure to chemicals will be investigated under static and dynamic flow conditions. The following research objectives are proposed. 1. Design an integrated GI-Liver platform using a primary intestinal cell sheet and a 3D multi-cellular hepatic organotypic culture model. 2. Investigate the integrated GI-Liver platform in the presence of dynamic flow. 3. Investigate the effect of chemicals using the GI-liver platform. With regard to broader impacts, the PI will conduct K-12 educational outreach through a weeklong activity for female high school students. The students will learn to identify changes in liver and GI systems upon adding chemicals. This activity will enable students to learn how to identify and formulate a research problem, to conduct statistical analyses, and to work in teams.

PUBLICATIONS PRODUCED AS A RESULT OF THIS RESEARCH

Note:  When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

(Showing: 1 - 10 of 11)
A. J. Ford and P. Rajagopalan "Measuring Cytoplasmic Stiffness of Fibroblasts as a Function of Substrate Rigidity Using Atomic Force Microscopy" ACS Biomaterials Science and Engineering , 2018 doi.org/10.1021/acsbiomaterials.8b01019
A. Kothari, P. Rajagopalan "Isolating Rat Intestinal Explants for In Vitro Cultures" Current Protocols in Toxicology , 2019 doi.org/10.1002/cptx.79
A. Kothari, P. Rajagopalan "The assembly of integrated rat intestinal-hepatocyte cultures" Bioengineering and Translational Medicine , 2019 DOI: 10.1002/btm2.10146
A. Kothari, P. Rajagopalan "The Isolation of Rat Intestinal Explants for In Vitro Cultures" Current Protocols in Toxicology , 2019 DOI: 10.1002/cptx.79
A.N. Tegge, R. R. Rodrigues, A. L. Larkin, L.T. Vu, T.M. Murali, P. Rajagopalan "Transcriptomic Analysis of HepaticCells in Multicellular OrganotypicLiver Models" Scientific Reports , v.8 , 2018 DOI:10.1038/s41598-018-29455-x
J.Law, K. Akers, N. Tasnina, C. Della Santina, M. Kshirsagar, J. Klein-Seetharaman, M. Crovella, P. Rajagopalan, S. Kasif, T.M. Murali "Identifying Human Interactors of SARS-CoV-2 Proteins and Drug Targets for COVID-19 using Network-Based Label Propagation" arXiv.org , 2020 arXiv:2006.01968v2 [q-bio.MN]
L. R. Wills, P. Rajagopalan "Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use inToxicity Testing" Annals of Biomedical Engineering , 2019 DOI: 10.1007/s10439-019-02331-z
L. Wills and P. Rajagopalan "Advances in Human Induced Pluripotent Stem Cell-Derived Hepatocytes for Use in Toxicity Testing" Annals of Biomedical Engineering , 2019 DOI : 10.1007/s10439-019-02331-z
S. M. Orbach, A.J. Ford, S. Saverot, P. Rajagopalan "Multi-Cellular Transitional Organotypic Models to Investigate LiverFibrosis" Acta Biomaterialia , 2018 doi: 10.1016/j.actbio.2018.10.010.
S. M. Orbach, M. F. Ehrich and P. Rajagopalan "High-throughput toxicity testing of chemicals and mixtures in organotypicmulti-cellular cultures of primary human hepatic cells" Toxicology In Vitro , v.51 , 2018 , p.83 doi.org/10.1016/j.tiv.2018.05.006
S.M. Orbach, R.R. Less, A. Kothari and P. Rajagopalan "In Vitro Intestinal and Liver Models for Toxicity Testing" ACS Biomaterials Science and Engineering , 2017 10.1021/acsbiomaterials.6b00699
(Showing: 1 - 10 of 11)

PROJECT OUTCOMES REPORT

Disclaimer

This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.

Intellectual Merit:

The metabolism of drugs and chemicals occurs due to close interactions between the gastrointedstinal tract and the liver.  These organs are connected via the portal vein, which carries metabolites and drugs from the intestine to the liver; and the bile duct, which brings the drugs, toxins and bile processed in the liver to the intestine. This enterohepatic circulation affects several physiological functions such as absorption and bioavailability of drugs, bile acid homeostasis and the urea cycle. Together, the gut-liver axis also affects the brain in crucial ways.  Understanding how these two organs communicate and work together could reveal new insights into their joint functions. We have cultured rat jejunum explants in vitro and integrated them with hepatocyte cultures. We have also investigated the changes in jejunum function at different locations. Such in vitro models may also be used for testing the effects of other chemicals or drugs in the future.

Broader Impact: 

The gut-liver axis plays a critical role in modulating several metabolic and biotransformation processes.  Obtaining a fundamental understanding on how these organs communicate provides new information that can be used to understand effects at the molecular, cellular and organ levels.  Integration of these tissues could also lead to the identification and acceleration of new insights into these organs and aid in toxicology as well as in the delivery of drugs.


Last Modified: 11/29/2020
Modified by: Padmavathy Rajagopalan

Please report errors in award information by writing to: awardsearch@nsf.gov.

Print this page

Back to Top of page